Adakveo

(crizanlizumab-tmca)
Check Coverage Restrictions
Or select your Insurance from the list below:

Dosage & Administration

Administer 5 mg/kg by intravenous infusion over a period of 30 minutes on Week 0, Week 2, and every 4 weeks thereafter.

See Full Prescribing Information for instructions on preparation and administration.

Adakveo Prescribing Information

Adakveo Prior Authorization Resources

Adakveo PubMed™ News